vs
Healthpeak Properties（DOC）与RAYONIER ADVANCED MATERIALS INC.（RYAM）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是RAYONIER ADVANCED MATERIALS INC.的1.7倍（$719.4M vs $417.5M），Healthpeak Properties净利率更高（73.2% vs -5.0%，领先78.2%），Healthpeak Properties同比增速更快（3.1% vs -1.2%），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 3.8%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
RYAM（原雷尼尔先进材料公司）是一家美国全球性纤维素技术企业，主打高纯度特种纤维素产品，所生产的天然聚合物广泛应用于过滤器生产、食品加工、医药制造及各类工业领域，同时也为造纸和包装行业供应相关产品，在纤维素技术领域拥有较高的行业认可度。
DOC vs RYAM — 直观对比
营收规模更大
DOC
是对方的1.7倍
$417.5M
营收增速更快
DOC
高出4.2%
-1.2%
净利率更高
DOC
高出78.2%
-5.0%
两年增速更快
DOC
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $417.5M |
| 净利润 | $114.0M | $-21.1M |
| 毛利率 | — | 8.9% |
| 营业利润率 | 17.4% | 2.6% |
| 净利率 | 73.2% | -5.0% |
| 营收同比 | 3.1% | -1.2% |
| 净利润同比 | 2406.4% | -31.9% |
| 每股收益（稀释后） | $0.16 | $-0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCRYAM
| Q4 25 | $719.4M | $417.5M | ||
| Q3 25 | $705.9M | $352.8M | ||
| Q2 25 | $694.3M | $340.0M | ||
| Q1 25 | $702.9M | $356.0M | ||
| Q4 24 | $698.0M | $422.5M | ||
| Q3 24 | $700.4M | $401.1M | ||
| Q2 24 | $695.5M | $419.0M | ||
| Q1 24 | $606.6M | $387.7M |
净利润DOCRYAM
| Q4 25 | $114.0M | $-21.1M | ||
| Q3 25 | $-117.1M | $-4.5M | ||
| Q2 25 | $31.7M | $-363.2M | ||
| Q1 25 | $42.8M | $-32.0M | ||
| Q4 24 | $4.5M | $-16.0M | ||
| Q3 24 | $85.9M | $-32.6M | ||
| Q2 24 | $146.0M | $11.4M | ||
| Q1 24 | $6.7M | $-1.6M |
毛利率DOCRYAM
| Q4 25 | — | 8.9% | ||
| Q3 25 | 58.6% | 9.7% | ||
| Q2 25 | 60.2% | 7.0% | ||
| Q1 25 | 61.1% | 6.8% | ||
| Q4 24 | 60.3% | 8.7% | ||
| Q3 24 | 60.0% | 10.9% | ||
| Q2 24 | 60.6% | 11.5% | ||
| Q1 24 | 59.8% | 9.5% |
营业利润率DOCRYAM
| Q4 25 | 17.4% | 2.6% | ||
| Q3 25 | 9.2% | 2.8% | ||
| Q2 25 | 5.7% | -0.4% | ||
| Q1 25 | 7.7% | -4.2% | ||
| Q4 24 | -2.2% | 2.6% | ||
| Q3 24 | 14.1% | -4.2% | ||
| Q2 24 | 22.3% | 6.7% | ||
| Q1 24 | 3.7% | 4.4% |
净利率DOCRYAM
| Q4 25 | 73.2% | -5.0% | ||
| Q3 25 | -16.6% | -1.3% | ||
| Q2 25 | 4.6% | -106.8% | ||
| Q1 25 | 6.1% | -9.0% | ||
| Q4 24 | 0.7% | -3.8% | ||
| Q3 24 | 12.3% | -8.1% | ||
| Q2 24 | 21.0% | 2.7% | ||
| Q1 24 | 1.1% | -0.4% |
每股收益（稀释后）DOCRYAM
| Q4 25 | $0.16 | $-0.33 | ||
| Q3 25 | $-0.17 | $-0.07 | ||
| Q2 25 | $0.05 | $-5.44 | ||
| Q1 25 | $0.06 | $-0.49 | ||
| Q4 24 | $0.02 | $-0.25 | ||
| Q3 24 | $0.12 | $-0.49 | ||
| Q2 24 | $0.21 | $0.17 | ||
| Q1 24 | $0.01 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $75.4M |
| 总债务越低越好 | $9.8B | $758.1M |
| 股东权益账面价值 | $7.5B | $316.6M |
| 总资产 | $20.3B | $1.8B |
| 负债/权益比越低杠杆越低 | 1.31× | 2.39× |
8季度趋势，按日历期对齐
现金及短期投资DOCRYAM
| Q4 25 | $467.5M | $75.4M | ||
| Q3 25 | $91.0M | $77.0M | ||
| Q2 25 | $89.4M | $70.7M | ||
| Q1 25 | $70.6M | $129.9M | ||
| Q4 24 | $119.8M | $125.2M | ||
| Q3 24 | $180.4M | $136.1M | ||
| Q2 24 | $106.9M | $114.1M | ||
| Q1 24 | $101.8M | $54.6M |
总债务DOCRYAM
| Q4 25 | $9.8B | $758.1M | ||
| Q3 25 | $9.1B | $763.5M | ||
| Q2 25 | $9.0B | $720.4M | ||
| Q1 25 | $8.9B | $707.0M | ||
| Q4 24 | $8.7B | $706.4M | ||
| Q3 24 | $8.6B | $747.7M | ||
| Q2 24 | $8.6B | $752.8M | ||
| Q1 24 | $8.8B | $755.6M |
股东权益DOCRYAM
| Q4 25 | $7.5B | $316.6M | ||
| Q3 25 | $7.6B | $338.2M | ||
| Q2 25 | $7.9B | $342.3M | ||
| Q1 25 | $8.2B | $688.1M | ||
| Q4 24 | $8.4B | $713.9M | ||
| Q3 24 | $8.6B | $732.7M | ||
| Q2 24 | $8.8B | $755.1M | ||
| Q1 24 | $8.9B | $741.8M |
总资产DOCRYAM
| Q4 25 | $20.3B | $1.8B | ||
| Q3 25 | $19.6B | $1.8B | ||
| Q2 25 | $19.8B | $1.8B | ||
| Q1 25 | $19.8B | $2.1B | ||
| Q4 24 | $19.9B | $2.1B | ||
| Q3 24 | $20.0B | $2.2B | ||
| Q2 24 | $20.2B | $2.2B | ||
| Q1 24 | $20.5B | $2.1B |
负债/权益比DOCRYAM
| Q4 25 | 1.31× | 2.39× | ||
| Q3 25 | 1.20× | 2.26× | ||
| Q2 25 | 1.14× | 2.10× | ||
| Q1 25 | 1.08× | 1.03× | ||
| Q4 24 | 1.04× | 0.99× | ||
| Q3 24 | 1.00× | 1.02× | ||
| Q2 24 | 0.98× | 1.00× | ||
| Q1 24 | 0.99× | 1.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $32.3M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCRYAM
| Q4 25 | $1.3B | $32.3M | ||
| Q3 25 | $315.0M | $-17.8M | ||
| Q2 25 | $363.5M | $-30.2M | ||
| Q1 25 | $279.4M | $39.6M | ||
| Q4 24 | $1.1B | $54.9M | ||
| Q3 24 | $318.2M | $49.8M | ||
| Q2 24 | $316.2M | $87.6M | ||
| Q1 24 | $152.6M | $11.3M |
自由现金流DOCRYAM
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOCRYAM
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCRYAM
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOCRYAM
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | 7.69× | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
RYAM
| Cellulose Specialties | $249.6M | 60% |
| Other | $86.2M | 21% |
| Paperboard | $44.2M | 11% |
| High Yield Pulp | $28.3M | 7% |
| Biomaterials | $9.2M | 2% |
